PCK2 and Insulin resistance: It has been shown that pharmacological blockade of 11β-HSD1 expression prevents the generation of active glucocorticoids and reduces hepatic GR expression, which in turn results in the suppression of both PEPCK and G6Pase mRNA expression and improvement of insulin resistance in diabetic db/db mice and obese Zucker rats [27].